Iatrogenic metrorrhagia after the use of itraconazole for onychomycosis
Author(s) -
SandraJerkovic Gulin,
Piotr Brzeziński,
Dario Gulin,
Anca Chiriac
Publication year - 2017
Publication title -
indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/ijp.ijp_838_16
Subject(s) - metrorrhagia , itraconazole , drug , medicine , dermatology , estrogen , pharmacology , antifungal , family planning , population , research methodology , environmental health
We present first case report on itraconazole, a drug very commonly used for onychomycosis, used along with simvastatin that caused metrorrhagia. The suggested probable mechanism is the inhibition of steroidogenesis, especially estrogens that resulted in low-estrogen breakthrough bleeding. This article emphasizes the importance of drug interaction check prior the initiation of onychomycosis treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom